Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus 1 Positive”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Testing effectiveness (Phase 2)Study completedNCT00002228
What this trial is testing

T-20 in HIV-Positive Adults

Who this might be right for
HIV Infections
Trimeris 78
Testing effectiveness (Phase 2)Study completedNCT01097070
What this trial is testing

Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days

Who this might be right for
HIV-1 Infection
Myrexis Inc. 35
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Not applicableStudy completedNCT00002236
What this trial is testing

Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn 32
Post-approval studies (Phase 4)Study completedNCT02057796
What this trial is testing

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 1,050
Early research (Phase 1)Study completedNCT00270465
What this trial is testing

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Study completedNCT00195234
What this trial is testing

Study Evaluating Vaccine in Adults With HIV

Who this might be right for
HIV Infections
Wyeth is now a wholly owned subsidiary of Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT01861730
What this trial is testing

Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants

Who this might be right for
Tuberculosis
Aeras 243
Large-scale testing (Phase 3)Study completedNCT01815736
What this trial is testing

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Who this might be right for
HIVHIV Infections
Gilead Sciences 1,443
Early research (Phase 1)Study completedNCT02378207
What this trial is testing

Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents

Who this might be right for
Tuberculosis
Aeras 84
Not applicableStudy completedNCT04089488
What this trial is testing

Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America

Who this might be right for
HIV InfectionHuman Immunodeficiency Virus 1 PositiveMalignant Neoplasm+1 more
AIDS Malignancy Consortium 175
Testing effectiveness (Phase 2)Study completedNCT00002361
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Not applicableWithdrawnNCT03660722
What this trial is testing

Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects

Who this might be right for
HIV Positive
Centre Hospitalier Universitaire de Saint Etienne
Not applicableStudy completedNCT00000932
What this trial is testing

The Long-Term Outcomes of HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,669
Not applicableUnknownNCT04887675
What this trial is testing

Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI

Who this might be right for
HIV I InfectionHIV Associated LipodystrophyMetabolic Syndrome+1 more
University of Novi Sad 120
Early research (Phase 1)Study completedNCT00054860
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Load More Results